Risk of Serious Infections in Patients with Ulcerative Colitis Treated with Tofacitinib Compared to Biologic Treatments in the United States

被引：0
|
作者：
Rubin, David T. [1 ]
Schreiber, Stefan [2 ]
Peyrin-Biroulet, Laurent [3 ,4 ]
Danese, Silvio [5 ]
Gianfrancesco, Milena [6 ]
Soonasra, Arif [7 ]
Sidhu, Sarah [6 ]
Vranic, Ivana [8 ]
Shelbaya, Ahmed [6 ]
Gruben, David [9 ]
Winthrop, Kevin [10 ]
Curtis, Jeffrey [11 ]
Regueiro, Miguel D. [12 ]
Dubinsky, Marla C. [13 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
[2] Univ Hosp Schleswig Holstein, Kiel, Germany
[3] Nancy Univ Hosp, INFINY Inst, FHU CURE, INSERM,NGERE, Vand?uvre Ies Nancy, Lorraine, France
[4] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[5] IRCCS San Raffaele Sci Inst, Milan, Lombardy, Italy
[6] Pfizer Inc, New York, NY USA
[7] Pfizer Inc, Collegeville, PA USA
[8] Pfizer Inc, Walton Oaks, England
[9] Pfizer Inc, Groton, CT USA
[10] Oregon Hlth & Sci Univ, Portland, OR USA
[11] Univ Alabama Birmingham, Birmingham, AL USA
[12] Cleveland Clin, Cleveland, OH USA
[13] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001033604.38645.83
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1059
引用
收藏
页码：S746 / S746
页数：1
相关论文
共 50 条
  • [31] The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database
    Seo, Gi Hyeon
    Jung, Sung Hoon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (16)
  • [32] Serious infections in hospitalized patients with psoriasis in the United States
    Hsu, Derek Y.
    Gordon, Kenneth
    Silverberg, Jonathan I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (02) : 287 - 296
  • [33] Emergent and Urgent Surgery for Ulcerative Colitis in the United States in the Minimally Invasive and Biologic Era
    Abd El Aziz, Mohamed A.
    Larson, David W.
    Grass, Fabian
    D'Angelo, Anne-Lise D.
    Kelley, Scott R.
    Raffals, Laura E.
    Mathis, Kellie L.
    Shawki, Sherief
    DISEASES OF THE COLON & RECTUM, 2022, 65 (08) : 1025 - 1033
  • [34] Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
    Taku Kobayashi
    Masato Hoshi
    Akira Yuasa
    Shoko Arai
    Mitsunobu Ikeda
    Hiroyuki Matsuda
    Seok-Won Kim
    Toshifumi Hibi
    PharmacoEconomics, 2023, 41 : 589 - 604
  • [35] Tofacitinib Is Associated With Increased Risk of Postoperative Venous Thromboembolism in Patients With Ulcerative Colitis
    Russell, Tara
    Banerjee, Sudeep
    Lipman, Jeremy
    Holubar, Stefan
    Hull, Tracy
    Steele, Scott
    Lightner, Amy
    DISEASES OF THE COLON & RECTUM, 2024, 67 (05) : 693 - 699
  • [36] SURGERY AND BIOLOGIC USE PATTERN FOR ULCERATIVE COLITIS PATIENTS INITIATED WITH INFLIXIMAB IN A MANAGED CARE SETTING IN THE UNITED STATES
    Muszka, J.
    Gorcyca, K.
    Herrera, V
    Wang, H.
    Badalamenti, S.
    Covington, M. T.
    VALUE IN HEALTH, 2013, 16 (03) : A199 - A199
  • [37] Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States
    Patel, Haridarshan
    Lissoos, Trevor
    Rubin, David T.
    PLOS ONE, 2017, 12 (04):
  • [38] Hospitalizations and Characteristics of Patients with Ulcerative Colitis and Crohn's Disease Treated with Vedolizumab in the United States
    Reynolds, Matthew
    Raluy-Callado, Mireia
    O'Hara, Don
    Alam, Naufil
    Smyth, Michael
    Khalid, Mona
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S17 - S17
  • [39] Obesity Is Not Associated With an Increased Risk of Serious Infections in Biologic-Treated Patients With Inflammatory Bowel Diseases
    Singh, Siddharth
    Heien, Herbert C.
    Sangaralingham, Lindsey
    Shah, Nilay D.
    Sandborn, William J.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (07)
  • [40] Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib
    van Gennep, Sara
    Fung, Ivan C. N.
    Jong, Djuna C. de
    Ramkisoen, Rishand K.
    Clasquin, Esme
    de Jong, Jitteke
    de Vries, Leonie C. S.
    de Jonge, Wouter J.
    Gecse, Krisztina B.
    Lowenberg, Mark
    Woolcott, John C.
    Mookhoek, Aart
    D'Haens, Geert R.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (08): : 1283 - 1291
12345